NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

自身免疫性肝炎 (AIH) 診斷和治療的全球市場(2021-2027)

Global Autoimmune Hepatitis Diagnosis and Treatment Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025408
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
自身免疫性肝炎 (AIH) 診斷和治療的全球市場(2021-2027) Global Autoimmune Hepatitis Diagnosis and Treatment Market 2021-2027
出版日期: 2021年07月13日內容資訊: 英文
簡介

在預測期內,自身免疫性肝炎 (AIH) 診斷和治療的全球市場預計將以約 5.7% 的顯著複合年增長率增長。在預測期內,醫療旅遊的增加、對疾病認識的提高、研發支出的增加以及慢性病發病率的增加將推動自身免疫性肝炎治療市場的增長。此外,生活方式和飲酒的改變是導致肝病的主要原因,世界各國對自身免疫性肝炎的診斷和治療需求日益增加。然而,藥物成本上升和熟練專業人員短缺等因素可能會阻礙自身免疫性肝炎藥物市場的增長。

COVID-19 危機期間,全球自身免疫性肝炎 (AIH) 診斷和治療市場出現下滑。對於 COVID-19,僅向急診和 COVID 患者提供醫療服務,減少了對自身免疫性肝炎和肝病患者的治療診斷和隨訪。

全球自身免疫性肝炎診斷和治療市場根據診斷、治療、類型和最終用戶進行分類。根據診斷,市場分為血液檢查、影像檢查和肝臟活檢。根據治療,市場分為藥物、皮質類固醇、免疫系統抑製劑和肝移植。此外,按類型分為I型、II型和變異型AIH。此外,根據最終用戶,它分為醫院/診所、診斷中心和研究機構。由於肝病診斷領域的知名利益相關者正致力於發展先進的診斷成像技術,因此成像領域有望佔據診斷領域的很大份額。

本報告調查了全球自身免疫性肝炎(AIH)診斷和治療市場,包括市場概況、市場增長和抑制因素分析、市場機會、診斷和治療方法、類型、最終用戶,並提供系統信息,如作為區域市場規模趨勢和預測、競爭條件以及主要公司的概況。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢
  • 規則

第 3 章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
  • 重要的戰略分析
  • COVID-19 對主要參與者的影響

第 4 章市場決定因素

  • 增長因素
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 按診斷
    • 驗血
    • 圖像檢查
    • 肝活檢
  • 按處理方法
    • 劑量
    • 皮質類固醇
    • 免疫系統抑製劑
    • 肝移植
  • 按類型
    • 類型 I
    • 類型 II
    • 變體 AIH
  • 最終用戶
    • 醫院和診所
    • 診斷中心
    • 研究機構

第 6 章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他領域

第 7 章公司簡介

  • Abbott Laboratories,
  • AbbVie, Inc.
  • Arihantanam Life Care Pvt Ltd.
  • AstraZeneca PLC
  • Bayer AG
  • Biocon, Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Co.
  • Cipla, Ltd.
  • GlaxoSmithKline PLC
  • Gilead Lifesciences, Inc.
  • Johnson & Johnson Services, Inc.
  • Inova Diagnostics, Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Organovo Holdings, Inc.
  • Pfizer, Inc.
  • Upcyte Technologies GmbH
目錄
Product Code: OMR2023837

Full-title:Global Autoimmune Hepatitis Diagnosis and Treatment Market Size, Share & Trends Analysis Report By Diagnosis ( Blood Test, Imaging Test, Liver Biopsy) By Treatment ( Medication, Corticosteroids, Immune System Suppressors, Liver Transplant), By Type (Type-I, Type-II, Variant AIH) End-User (Hospitals & Clinics,& Diagnostic Centre, and Research Institutions) Forecast Period 2021-2027.

The global autoimmune hepatitis diagnosis and treatment market is anticipated to grow at a substantial CAGR of around 5.7% during the forecast period. Growing medical tourism, rise in the awareness of the condition prevailing, increased R&D funding, and increasing incidence of the chronic condition drive the growth of the autoimmune hepatitis therapeutics market during the forecast period. Furthermore, changes in lifestyle and alcohol consumption are causing major liver diseases and increasing demand for autoimmune hepatitis diagnosis and treatment around the world. However, factors such as rising drug costs, and a lack of skilled professionals may hamper the growth of the autoimmune hepatitis therapeutics market.

The global Autoimmune Hepatitis Diagnosis and Treatment market suffered a downfall during the COVID-19 crisis. As only emergency cases and covid patients were provided healthcare services during the COVID-19, therefore there was a decrease in the treatment diagnosis as well as the follow-up of patients with autoimmune hepatitis and liver diseases.

The global autoimmune hepatitis diagnosis and treatment market are segmented based on diagnosis, treatment, types, and end-user. Based on the diagnosis, the market is segmented into blood tests, imaging tests, and liver biopsy. Based on treatment, the market is segmented into Medication, corticosteroids, immune system suppressors, liver transplants. Further, based on type the market is segregated into Type-I, Type-II, Variant AIH. Furthermore, on the basis of end-user, the market is classified into hospitals & clinics, diagnostic centers, and research institutions. The imaging test sub-segment is expected to have a significant share among diagnoses due to an increase in the series of initiatives introduced by prominent stakeholders in liver disease diagnostics to develop advanced imaging techniques.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is projected to have a significant market share in the autoimmune hepatitis diagnosis and treatment market. The growth is witnessed due to the prevalence of the liver disease is increasing that is resulted from the consumption of large amounts of alcohol and illegal drugs. This can also result in a liver condition known as alcoholic hepatitis which causes liver inflammation and requires treatment therefore these factors are driving the market growth in North America. The key players of the autoimmune hepatitis diagnosis and treatment market include Gilead Lifesciences, Inc., Merck & Co., Inc., Bio-Rad Laboratories, Inc. Novartis International AG, Abbott Laboratories, and others.

Research Methodology

The market study of the Autoimmune Hepatitis Diagnosis market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Autoimmune Hepatitis Diagnosis Market Research and Analysis by Diagnosis
  • Autoimmune Hepatitis Diagnosis Market Research and Analysis by Treatment
  • Autoimmune Hepatitis Diagnosis Market Research and Analysis by Type
  • Autoimmune Hepatitis Diagnosis Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the autoimmune hepatitis diagnosis
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the autoimmune hepatitis diagnosis and treatment market.
  • Insights about market determinants that are stimulating the autoimmune hepatitis diagnosis market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Autoimmune Hepatitis Diagnosis and Treatment Industry
  • Recovery Scenario of Global Autoimmune Hepatitis Diagnosis and Treatment Industry
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis
    • 5.1.1. Blood Test
    • 5.1.2. Imaging Test
    • 5.1.3. Liver Biopsy
  • 5.2. Global Autoimmune Hepatitis Diagnosis and Treatment market by Treatment
    • 5.2.1. Medication
    • 5.2.2. Corticosteroids
    • 5.2.3. Immune System Suppressors
    • 5.2.4. Liver Transplant
  • 5.3. Global Autoimmune Hepatitis Diagnosis and Treatment market by Type
    • 5.3.1. Type-I
    • 5.3.2. Type-II
    • 5.3.3. Variant AIH
  • 5.4. Global Autoimmune Hepatitis Diagnosis and Treatment market by End-User
    • 5.4.1. Hospitals and Clinics
    • 5.4.2. Diagnostic Centre
    • 5.4.3. Research Institutions

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories,
  • 7.2. AbbVie, Inc.
  • 7.3. Arihantanam Life Care Pvt Ltd.
  • 7.4. AstraZeneca PLC
  • 7.5. Bayer AG
  • 7.6. Biocon, Ltd.
  • 7.7. Bio-Rad Laboratories, Inc.
  • 7.8. Bristol-Myers Squibb Co.
  • 7.9. Cipla, Ltd.
  • 7.10. GlaxoSmithKline PLC
  • 7.11. Gilead Lifesciences, Inc.
  • 7.12. Johnson & Johnson Services, Inc.
  • 7.13. Inova Diagnostics, Inc.
  • 7.14. Merck & Co., Inc.
  • 7.15. Novartis International AG
  • 7.16. Organovo Holdings, Inc.
  • 7.17. Pfizer, Inc.
  • 7.18. Upcyte Technologies GmbH

LIST OF TABLES

  • 1. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR BLOOD TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR IMAGING TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR LIVER BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 6. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR MEDICATION MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 7. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR IMMUNE SYSTEM SUPPRESSORS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT IN LIVER TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 11. GLOBAL TYPE-I AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL TYPE-II AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL VARIANT AIH AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENTMARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 15. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS BY REGION 2020-2027 ($ MILLION)
  • 17. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT FOR RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION 2020-2027 ($ MILLION)
  • 18. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 22. NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 24. EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 26. EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 27. EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 28. EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 32. ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS 2020-2027 ($ MILLION)
  • 36. REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET, 2020-2027 (%)
  • 4. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2020 VS 2027 (%)
  • 5. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2020 VS 2027 (%)
  • 6. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 7. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY END-USER 2020 VS 2027 (%)
  • 8. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL BLOOD TEST FOR AUTOIMMUNE HEPATITIS DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 10. GLOBAL IMAGING TEST FOR AUTOIMMUNE HEPATITIS DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL LIVER BIOPSY FOR AUTOIMMUNE HEPATITIS DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBAL MEDICATION FOR AUTOIMMUNE HEPATITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBAL CORTICOSTEROIDS FOR AUTOIMMUNE HEPATITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. GLOBAL IMMUNE SYSTEM SUPPRESSORS FOR AUTOIMMUNE HEPATITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 15. GLOBAL LIVER TRANSPLANT FOR AUTOIMMUNE HEPATITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 16. GLOBAL TYPE-I AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 17. GLOBAL TYPE-II AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 18. GLOBAL VARIANT AIH AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 19. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT IN HOSPITALS AND CLINICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 20. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT IN DIAGNOSTIC CENTRE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 21. GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT IN RESEARCH INSTITUTIONS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 22. US AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 23. CANADA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 24. UK AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 25. FRANCE AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 26. GERMANY AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 27. ITALY AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 28. SPAIN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 29. REST OF EUROPE AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 30. INDIA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 31. CHINA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 32. JAPAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 33. SOUTH KOREA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 34. REST OF ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)
  • 35. REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2020-2027($ MILLION)